NA
SNY icon

Navellier & Associates’s Sanofi SNY Stock Holding History

Navellier & Associates’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-34
Closed -$2K – 299
2015
Q3 		$2K Sell
34
-8,319
-100% -$424K ﹤0.01% 295
2015
Q2 		$414K Buy
8,353
+642
+8% +$32.5K 0.04% 232
2015
Q1 		$381K Sell
7,711
-489
-6% -$23.4K 0.03% 247
2014
Q4 		$374K Sell
8,200
-67
-0.8% -$3.25K 0.02% 230
2014
Q3 		$467K Sell
8,267
-1,088
-12% -$58.4K 0.02% 191
2014
Q2 		$497K Sell
9,355
-564
-6% -$29.9K 0.02% 192
2014
Q1 		$519K Sell
9,919
-72
-0.7% -$3.65K 0.02% 168
2013
Q4 		$536K Buy
9,991
+1,977
+25% +$102K 0.02% 173
2013
Q3 		$406K Buy
8,014
+423
+6% +$21.5K 0.01% 200
2013
Q2 		$391K Buy
+7,591
New +$404K 0.02% 165

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Navellier & Associates's SNY Position: Q4 2015 in Review

Navellier & Associates sold out of Sanofi (SNY) in Q4 2015, closing a stake of 34 shares — an estimated $2K sold.

Navellier & Associates first reported a position in SNY in Q2 2013 and held it in 10 quarters. The position peaked at $536K in Q4 2013. 477 funds tracked by Wall St. Rank hold SNY as of Q4 2015.

  • Navellier & Associates reported no remaining Sanofi position as of Q4 2015 after selling out during the quarter.
  • Navellier & Associates sold 34 Sanofi shares in Q4 2015, an estimated $2K.
  • Navellier & Associates first reported a position in Sanofi in Q2 2013 and held it in 10 quarters.
  • Navellier & Associates's Sanofi position peaked at $536K in Q4 2013.
  • 477 funds tracked by Wall St. Rank held Sanofi as of Q4 2015.

Based on Navellier & Associates's 13F filing for Q4 2015, filed 10 Feb 2016.